PPARγ Agonists: Blood Pressure and Edema
Peroxisome proliferator activated receptor γ (PPARγ) agonists are widely used in the treatment of type 2 diabetes. Side effects of drug treatment include both fluid retention and a lowering of blood pressure. Data from animal and human studies suggest that these effects arise, at least in part, fr...
Saved in:
| Main Author: | Bonnie L. Blazer-Yost |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2010/785369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidiabetic Effect of Dihydrobetulonic Acid Derivatives as Pparα/γ Agonists
by: Mikhail V. Khvostov, et al.
Published: (2024-12-01) -
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γ Agonists
by: Martin B. Oleksiewicz, et al.
Published: (2008-01-01) -
Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-γ Agonists
by: Catherine Gurley, et al.
Published: (2008-01-01) -
Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γ Agonist against MPTP
by: Christine R. Swanson, et al.
Published: (2013-01-01) -
PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal Villi
by: Dory Gómez, et al.
Published: (2016-01-01)